EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus

Won-Jong Park iD, Gi-Sang Bae, Youn-Ho Han

Pathogens · 2024

DOI: 10.3390/pathogens13090761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Won-Jong Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic…. Hauptthemen laut MEDLINE: Antiviral Agents, Angelica, Influenza A Virus, H1N1 Subtype, Plant Extracts. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The influenza A virus poses a serious threat to human health and is an important global public health issue. The drugs currently used for treatment are becoming increasingly ineffective against influenza A viruses and require the development of new antiviral drugs. Angelica tenuissima Nakai (ATN), a traditional herbal medicine belonging to the Umbelliferae family, exhibits a broad range of pharmacological activities, including inflammation, headache, and cold symptoms. In the present study, based on target protein identification, functional enrichment analysis, and gene set comparisons, we first suggested that ATN has potential therapeutic effects against influenza A virus infection. Next, methylthiazol tetrazolium (MTT) and sulforhodamine B colorimetric (SRB) assay results revealed that ATN exhibited low cytotoxicity in Madin–Darby canine kidney (MDCK) cells. The antiviral properties of ATN were observed against H1N1 and H3N2 virus strains. Microscopy confirmed the increased survival rate of the host cells. Further time-of-addition experiments revealed that the addition of ATN before virus adsorption showed similar results to the whole period of treatment. The pre- and co-treated groups showed lower levels of viral RNA (M1 protein). The results of this study suggest that ATN exhibits antiviral properties against the influenza A virus. These therapeutic properties of ATN can serve as a theoretical basis for further research on the applicability of ATN in the development of antiviral agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsAngelicaInfluenza A Virus, H1N1 SubtypePlant ExtractsDogsAnimalsMadin Darby Canine Kidney CellsVirus ReplicationInfluenza A Virus, H3N2 SubtypeHumansInfluenza A virusInfluenza, Human

Stichwörter der Autor:innen

Angelica tenuissima Nakaiantiviralinfluenza A virus

Substanzen

Antiviral AgentsPlant Extracts

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Department of Pharmacology, School of Korean Medicine, Wonkwang University, Iksan 54538, Republic of Korea.
  • Department of Oral Pharmacology, College of Dentistry, Wonkwang University, Iksan 54538, Republic of Korea.

ORCID-Profile: Won-Jong Park

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Park, W. J., Bae, G. S., & Han, Y. H. (2024). Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus. Pathogens. https://doi.org/10.3390/pathogens13090761

Vancouver

Park WJ, Bae GS, Han YH. Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus. Pathogens. 2024. doi:10.3390/pathogens13090761

BibTeX
@article{Park2024,
  author = {Park, Won-Jong and Bae, Gi-Sang and Han, Youn-Ho},
  title = {Antiviral Activity of Angelica Tenuissima Nakai against Influenza A Virus},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13090761}
}
Kostenlos starten →